Order results by:
| Issue | Title | |
| Vol 19, No 6 (2023) | Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible? | Abstract similar documents |
| V. D. Zakiev, N. M. Vorobyeva, I. P. Malaya, A. D. Gvozdeva, O. N. Tkacheva | ||
| "... use of beta-blockers in CHF patients with preserved LV EF in the absence of other indications for them ..." | ||
| Vol 12, No 3 (2016) | PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, A. V. Zakharova, M. M. Loukianov, A. N. Vorobyev, K. A. Moseichuk, A. N. Kozminsky | ||
| "... Aim. To assess real clinical practice of prescribing beta-blockers (BB) and its compliance ..." | ||
| Vol 8, No 6 (2012) | TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE | Abstract similar documents |
| O. D. Ostroumova, G. N. Shchukina, V. M. Fomina | ||
| "... Advantages of metoprolol succinate in patients with chronic heart failure (CHF) are covered ..." | ||
| Vol 4, No 3 (2008) | HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA | Abstract similar documents |
| A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova | ||
| "... and various beta-blockers (atenolol, metoprolol, bisoprolol). These beta-blockers were changed for carvedilol ..." | ||
| Vol 6, No 5 (2010) | WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT? | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov | ||
| "... with chronic heart failure (CHF) and to study efficacy and safety of beta-blockers therapy. Material ..." | ||
| Vol 17, No 5 (2021) | Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers | Abstract similar documents |
| V. N. Larina, M. V. Leonova | ||
| "... , a reduced effect of the effect on myocardial remodeling in patients with CHF for beta-blockers in carriers ..." | ||
| Vol 13, No 4 (2017) | CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA | Abstract similar documents |
| S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, Yu. V. Lukina, M. M. Loukianov, A. N. Vorobyev, A. N. Kozminsky | ||
| "... Aim. To assess the practice of using beta-adrenoblockers (β-AB) in patients with cardiovascular ..." | ||
| Vol 3, No 5 (2007) | EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| I. V. Vologdina | ||
| "... formulation) on quality of life in elderly patients with chronic heart failure (CHF) of ischemic etiology ..." | ||
| Vol 9, No 5 (2013) | PRIMARY CARE PROBLEMS IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| O. A. Shtegman | ||
| "... received target doses of ACE inhibitors/sartans and beta-blockers, respectively. Majority of CHF ..." | ||
| Vol 4, No 3 (2008) | ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW? | Abstract similar documents |
| S. Y. Martsevich | ||
| "... The beta-blocker role in arterial hypertension treatment is surveyed from the positions of evidence ..." | ||
| Vol 13, No 3 (2017) | BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL | Abstract similar documents |
| I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov | ||
| "... -blockers, the use of beta-adenoblocker with vasodilating activity, in particular carvedilol, makes ..." | ||
| Vol 17, No 3 (2021) | Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches | Abstract similar documents |
| A. A. Shchendrygina, K. A. Zhbanov, E. V. Privalova, A. O. Yusupova, Yu. A. Danilogorskaya, E. Yu. Salakheeva, I. Ya. Sokolova, S. A. Tsatsurova, A. A. Ageeva, Yu. N. Belenkov | ||
| Vol 4, No 2 (2008) | BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL | Abstract similar documents |
| A. N. Zakirova, F. S. Zarudij, B. N. Garifullin | ||
| "... Approaches evolution to studying of beta-blockers influence on platelet aggregation is reviewed ..." | ||
| Vol 6, No 1 (2010) | THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE | Abstract similar documents |
| Yu. V. Lukina, S. Yu. Martsevich | ||
| Vol 4, No 4 (2008) | BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST | Abstract similar documents |
| L. N. Malaj | ||
| "... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..." | ||
| Vol 11, No 6 (2015) | The first Russian register of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov, N. V. Romanova, Yu. F. Osmolovskaya, S. P. Golitsyn | ||
| "... Chronic heart failure (CHF) and atrial fibrillation (AF) can rightly be called the epidemic ..." | ||
| Vol 16, No 3 (2020) | Angiogenesis in Patients with Chronic Heart Failure: Focus on Endothelial Vascular Growth Factor, Pentraxin-3 and Transforming Growth Factor Beta | Abstract similar documents |
| R. N. Shepel, O. M. Drapkina | ||
| "... Chronic heart failure (CHF) is considered the leading cause of death in patients with established ..." | ||
| Vol 13, No 2 (2017) | PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) | Abstract similar documents |
| M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov | ||
| "... and stroke history, more severe course of CHF, HT and IHD, greater prescription rate of β-blockers ..." | ||
| Vol 5, No 4 (2009) | METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER | Abstract similar documents |
| B. N. Garifullin, A. N. Zakirova, F. S. Zarudij | ||
| "... Results of large randomized clinical trails on beta-blockers therapy of myocardial infarction (MI ..." | ||
| Vol 7, No 2 (2011) | SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY | Abstract similar documents |
| E. V. Filippov, S. S. Yakushin | ||
| "... is pharmacotherapy. Overview of various drugs is given. The largest evidence base and proven efficacy have beta ..." | ||
| Vol 13, No 6 (2017) | THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
| A. N. Zakirova, B. N. Garifullin, N. E. Zakirova | ||
| "... in experimental data. Carvedilol is a third-generation beta-blocker with additional pleiotropic and antioxidant ..." | ||
| Vol 6, No 6 (2010) | THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS | Abstract similar documents |
| Yu. A. Bunin | ||
| "... and VA only beta-blockers and amiodarone are able to reduce mortality, while other drugs have no effect ..." | ||
| Vol 6, No 6 (2010) | THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina | ||
| "... Basic principles of beta-blockers choice strategy are presented. Attention is focused on the facts ..." | ||
| Vol 6, No 5 (2010) | EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY | Abstract similar documents |
| O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva | ||
| "... . To evaluate the efficacy and safety of beta-blocker bisoprolol in the perioperative period in hypertensive ..." | ||
| Vol 9, No 4 (2013) | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? | Abstract similar documents |
| V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev | ||
| "... attention has recently been focused on the use of beta-blockers in the postoperative period. Nowadays ..." | ||
| Vol 9, No 5 (2013) | THE ASSESSMENT AND REDUCTION OF CARDIAC EVENTS RISK IN NONCARDIAC OPERATIONS: IS THERE A NEED FOR REVIEW OF RECOMMENDATIONS? | Abstract similar documents |
| A. N. Sumin | ||
| "... the available scientific evidence. In this review we discussed in detail the use of beta-blockers in noncardiac ..." | ||
| Vol 8, No 4 (2012) | EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS | Abstract similar documents |
| I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze | ||
| "... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..." | ||
| Vol 18, No 6 (2022) | The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation | Abstract similar documents |
| A. S. Ryazanov, E. V. Shikh, O. V. Kechina, M. V. Makarovskaya, A. A. Kudryavtsev | ||
| "... parameters in patients with chronic heart failure (CHF) and functional mitral regurgitation (FMR) under ..." | ||
| Vol 18, No 2 (2022) | Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva | ||
| "... of chronic heart failure (CHF). Materials and methods. The study included 90 hospitalized patients ..." | ||
| Vol 17, No 3 (2021) | Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome | Abstract similar documents |
| A. Yu. Proshlyakov, P. Sh. Chomakhidze, N. A. Novikova | ||
| "... . A positive result of treatment depends on the severity of long QT syndrome and its genotype. Beta-blockers ..." | ||
| Vol 8, No 1 (2012) | BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE | Abstract similar documents |
| M. V. Leonova | ||
| "... Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented ..." | ||
| Vol 8, No 5 (2012) | THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN | Abstract similar documents |
| R. I. Striuk, Ya. V. Brytkova | ||
| Vol 15, No 5 (2019) | Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris | Abstract similar documents |
| V. V. Kashtalap, O. L. Barbarash, D. Yu. Sedykh, K. E. Krivoshapova, D. P. Tsygankova, O. V. Tsygankova | ||
| "... Aim. To evaluate the therapeutic efficacy of a combination of ivabradine and beta-blockers (BAB ..." | ||
| Vol 6, No 2 (2010) | NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER | Abstract similar documents |
| T. Műnzel, T. Gori | ||
| "... . Nebivolol. The somewhat-different β-adrenergic receptor blocker was initially published in J Am Coll Cardiol ..." | ||
| Vol 9, No 3 (2013) | THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS | Abstract similar documents |
| M. A. Maksimova, Yu. V. Lukina, S. Yu. Martsevich | ||
| "... Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β ..." | ||
| Vol 17, No 5 (2021) | Study of the Quality of Medical Therapy and Adherence in Patients with Chronic Heart Failure (According to the COMPLIANCE Study) | Abstract PDF (Eng) similar documents |
| E. T. Guseynova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, S. V. Blagodatskih, O. M. Drapkina, S. Yu. Martsevich | ||
| "... with CHF. Results. According to the results of the study, beta-blockers were prescribed to 70 (97 ..." | ||
| Vol 14, No 1 (2018) | COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 | Abstract similar documents |
| O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman | ||
| "... of combination therapy in 2014-2015, the frequency of the prescription of the ACE inhibitor+beta-blocker and ACE ..." | ||
| Vol 12, No 2 (2016) | ENDOTHELIAL DYSFUNCTION AND ROLE NITRATES AND BETA-BLOCKERS IN ITS CORRECTION IN ISCHEMIC HEART DISEASE | Abstract similar documents |
| A. N. Britov | ||
| "... . The treating effect of some medicinal products (nitrates, beta-blockers and others) is analyzed from the point ..." | ||
| Vol 5, No 2 (2009) | COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich | ||
| Vol 5, No 4 (2009) | BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES | Abstract similar documents |
| G. N. Gorokchovskaya, M. M. Petina | ||
| "... Beta-blockers application in modern cardiologic practice is reviewed with focus on beta-blocker ..." | ||
| Vol 7, No 2 (2011) | A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina | ||
| Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
| "... recommended for patients with a history of myocardial infarction (antiplatelets – 91.76%, beta-blockers – 83 ..." | ||
| Vol 10, No 4 (2014) | TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE | Abstract similar documents |
| O. V. Gaisenok, O. A. Zamyatina, N. Yu. Denisova, A. S. Leonov | ||
| Vol 3, No 3 (2007) | COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
| S. N. Tolpygina, E. V. Shilova, S. Y. Martsevich | ||
| Vol 5, No 1 (2009) | COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL | Abstract similar documents |
| S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina | ||
| "... received C 12,5 mg BID (Vedicardol, “Sintez”), another part – M 25 mg/day BID. Doubling dose of β-blockers ..." | ||
| Vol 17, No 5 (2021) | Peculiarities of Adverse Events Manifested by Injury of Skin and Skin Derivatives and Associated with Beta-blockers Use | Abstract similar documents |
| A. V. Matveev, E. A. Egorova, E. I. Konyaeva, A. G. Dormidor, E. Yu. Bekirova | ||
| "... that can lower the heart rate, beta-blockers (BAB) are still widely used in the pharmacotherapy ..." | ||
| Vol 16, No 4 (2020) | Evaluating Adherence to Medical Therapy in Patients with Chronic Heart Failure: Design and First Results of the COMPLIANCE Study | Abstract similar documents |
| S. Yu. Martsevich, E. T. Guseynova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, S. V. Blagodatskih | ||
| "... (ACEI)/angiotensin receptor blockers (ARB). Beta-blockers (BB) were prescribed to 96.7% of patients ..." | ||
| Vol 1, No 3 (2005) | CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL | Abstract similar documents |
| M. A. Statsenko, I. A. Sporova, S. V. Belenkova, N. N. Shilina | ||
| "... including both beta-blockers resulted in clinical improvement, increase in myocardial contractility. However ..." | ||
| Vol 3, No 1 (2007) | CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA | Abstract similar documents |
| M. V. Melnik, A. M. Shilov, I. R. Kim, O. N. Retivykh, A. A. Saricheva | ||
| "... CHF therapy (angiotensin converting enzyme inhibitors, β-emblockers/em, diuretics, cardiac glycosides ..." | ||
| Vol 17, No 3 (2021) | Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension | Abstract similar documents |
| E. V. Kokhan, G. K. Kiyakbaev, E. M. Ozova, V. A. Romanova, Zh. D. Kobalava | ||
| "... Aim. To study the impact of heart rate (HR) reduction with embeta/em-emblockers/em (BB) on left atrial (LA ..." | ||
| Vol 7, No 1 (2011) | TIMING OF PRE-OPERATIVE BETA-BLOCKER TREATMENT IN VASCULAR SURGERY PATIENTS: INFLUENCE ON POST-OPERATIVE OUTCOME | similar documents |
| W.-J. Flu, J.-P. van Kuijk, M. Chonchol, T. A. Winkel, H.J.M. Verhagen, J. J. Bax, D. Poldermans | ||
| Vol 5, No 5 (2009) | EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES | Abstract similar documents |
| O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova | ||
| Vol 6, No 2 (2010) | CLINICAL APPROACHES TO INTERPRETATION OF CLINICAL TRAILS RESULTS ON BETA-BLOCKERS FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| S. R. Giljarevskiy, I. M. Kuzmina | ||
| "... Modern approaches to a choice of embeta/em-emblockers/em for treatment of patients with chronic heart ..." | ||
| Vol 20, No 5 (2024) | Early intravenous beta-blockers injection in patients with acute STEMI: the results of the Russian registry REGION-IM | Abstract similar documents |
| T. S. Sukhinina, M. A. Terenicheva, R. G. Gulyan, R. M. Shakhnovich, O. V. Stukalova, O. A. Saygina, I. S. Yavelov, D. V. Pevsner | ||
| "... Aim. To study the features of the appointment of embeta/em-emblockers/em (BB) therapy in the early stages ..." | ||
| Vol 9, No 3 (2013) | PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY | Abstract similar documents |
| S. A. Rumyantseva, R. G. Oganov, V. A. Stupin, E. V. Silina, A. S. Orlova, S. B. Bolevich, V. V. Afanasev, E. N. Kabaeva, S. A. Volik | ||
| "... correcting therapy including embeta/em-oxidation emblocker/em (meldonium) is discussed. ..." | ||
| Vol 9, No 6 (2013) | COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY | Abstract similar documents |
| I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko | ||
| "... or embeta/em-emblocker/em carvedilol in patients with chronic heart failure (emCHF/em) due to dilated cardiomyopathy ..." | ||
| Vol 8, No 4 (2012) | HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| V. P. Lupanov | ||
| "... Review is devoted to the role of modern embeta/em-emblocker/em nebivolol in the treatment of stable ischemic ..." | ||
| Vol 7, No 5 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva | ||
| Vol 7, No 6 (2011) | EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS | Abstract similar documents |
| V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova | ||
| Vol 9, No 5 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... hospital. In specialized hospital the rate of aspirin use increased by 30%, statins - by 80%, embeta/em-emblockers/em ..." | ||
| Vol 9, No 5 (2013) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL LOW-DOSE BISOPROLOL/HYDROCHLOROTHIAZIDE COMBINATION IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES. RESULTS OF CLINICAL RANDOMIZED CROSSOVER STUDY | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, A. V. Zakharova, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, N. V. Kiseleva | ||
| Vol 1, No 1 (2005) | DRUGS AND SMOKING | Abstract similar documents |
| J. V. Lukina | ||
| "... in smokers. Aim. To compare efficacy and safety of selective and non-selective embeta/em–adrenoceptor emblockers/em ..." | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... in patients with stable angina significantly increased: antiplatelets – up to 82.7%, embeta/em-emblockers/em – up to 74 ..." | ||
| Vol 12, No 1 (2016) | Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease | Abstract similar documents |
| E. I. Tarlovskaya, T. I. Chudinovskikh | ||
| Vol 15, No 1 (2019) | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength | Abstract similar documents |
| I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova | ||
| "... of cardiovascular drugs, such as statins, embeta/em-emblockers/em, ACE inhibitors, diuretics, calcium antagonists and nitrates ..." | ||
| Vol 17, No 3 (2021) | Chronic Heart Failure in Patients with Arterial Hypertension Associated with Obstructive Sleep Apnea Syndrome: Possible Options to Pathogenetic Therapy | Abstract similar documents |
| A. V. Yakovlev, S. N. Shilov, E. N. Berezikova, N. F. Yakovleva, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, I. A. Efremov | ||
| "... is at least 2 years. Patients received drug therapy, including embeta/em-emblockers/em, mineralocorticoid receptor ..." | ||
| Vol 5, No 1 (2009) | ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT? | Abstract similar documents |
| S. Y. Martsevich | ||
| "... The role of embeta/em-emblockers/em (BB) in arterial hypertension therapy is discussed from the evidence ..." | ||
| Vol 6, No 1 (2010) | ANTIHYPERTENSIVE EFFICACY AND VASOPROTECTIVE PROPERTIES OF A NEW COMBINATION OF BETA-BLOCKER, BISOPROLOL (2,5/5 MG) AND DIURETIC, HYDROCHLOROTHIAZIDE (6,25 MG) | Abstract similar documents |
| O. D. Ostroumova, A. G. Sazonova, K. U. Reznikova, A. V. Srednjakov, E. A. Smolyarchuk | ||
| "... of selective embeta/em1-adrenoblocker (BIS 2.5-5 mg) and diuretic (HCT 6,25 mg). Initially and in 12 weeks ..." | ||
| Vol 4, No 3 (2008) | URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES | Abstract similar documents |
| M. P. Savenkov, A. S. Volkova, A. V. Kirienko, S. N. Ivanov, S. V. Ivanov | ||
| "... Aim. To compare urodynamic effects of embeta/em-emblockers/em with different selectivity (propranolol ..." | ||
| Vol 16, No 5 (2020) | Comparative Characteristics of Patients with Cerebral Stroke and Myocardial Infarction in Outpatient Practice: Structure of Comorbidity, Risk Factors, Drug Treatment and Outcomes | Abstract similar documents |
| A. N. Vorobyev, K. G. Pereverzeva, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, E. Yu. Okshina, O. M. Drapkina | ||
| "... receptor emblockers/em (ARBs) in emCHF/em, embeta/em-emblockers/em in emCHF/em and MI history, statins in CHD, antiplatelet agents ..." | ||
| Vol 14, No 2 (2018) | PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS | Abstract similar documents |
| S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov | ||
| "... Aim. To perform pharmacoeconomic analysis of emCHF/em therapy with supramolecular sacubitril/valsartan ..." | ||
| Vol 4, No 2 (2008) | MILDRONATE EFFECT ON ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CHRONIC HEART FAILURE: DOUBLE BLIND CROSSOVER STUDY | Abstract similar documents |
| L. G. Voronkov, A. A. I.Shkurat, E. A. Lutsak | ||
| "... failure (emCHF/em). Material and methods. 30 patients with emCHF/em taking standard therapy (diuretic, ACE ..." | ||
| Vol 7, No 3 (2011) | EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) | Abstract similar documents |
| A. P. Rebrov, N. A. Kosheleva | ||
| "... (emCHF/em) during three year follow-up. Material and methods. A total of 211 patients with emCHF/em experienced ..." | ||
| Vol 9, No 1 (2013) | MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS | Abstract similar documents |
| O. M. Drapkina, B. B. Gegenava | ||
| Vol 14, No 4 (2018) | Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment | Abstract similar documents |
| Yu. A. Bunin, S. A. Miklisanskaya, V. V. Chigineva, E. A. Zolozova | ||
| "... revascularization, radiofrequency catheter ablation, normalization of electrolyte imbalance, use of embeta/em-emblockers/em ..." | ||
| Vol 3, No 1 (2007) | RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY | Abstract similar documents |
| M. L. Maximov | ||
| "... heart failure (emCHF/em) as well as data of own study on nebivolol efficacy and tolerability in 113 patients ..." | ||
| Vol 7, No 3 (2011) | TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR | Abstract similar documents |
| I. M. Sokolov | ||
| "... medications that slow down HR: embeta/em emblockers/em (BB), If-channel inhibitors, nondihydropyridine calcium channel ..." | ||
| Vol 20, No 4 (2024) | The evolution of evidence-based methods of acute myocardial infarction treatment: is there any reason for optimism in recent years? | Abstract similar documents |
| S. Yu. Martsevich | ||
| "... that none of these studies gave a positive result. A new study with embeta/em-emblockers/em, which proved its positive ..." | ||
| Vol 5, No 3 (2009) | ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| S. N. Tereshchenko, N. A. Dzhaiani | ||
| "... The role of ACE inhibitors in modern pharmacotherapy of patients with chronic heart failure (emCHF/em ..." | ||
| Vol 10, No 3 (2014) | NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS | Abstract similar documents |
| O. M. Drapkina, L. O. Palatkina | ||
| "... with the severity of chronic heart failure (emCHF/em). Increasing number of patients with symptoms of emCHF/em but without ..." | ||
| Vol 12, No 6 (2016) | HEART FAILURE AND DIABETES MELLITUS: SELECTED ISSUES OF ETIOLOGY AND PATHOGENESIS, PROGNOSIS AND TREATMENT | Abstract similar documents |
| B. U. Mardanov, M. N. Korneeva, E. B. Akhmedova | ||
| "... of chronic heart failure (emCHF/em) and diabetes mellitus (DM). The modern views on the epidemiology, pathogenesis ..." | ||
| Vol 15, No 5 (2019) | Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) | Abstract similar documents |
| E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
| "... -emblockers/em in emCHF/em – 39% and 23.8% (p=0.002), respectively. During 4- year follow-up in the group ACVA+MI ..." | ||
| Vol 2, No 4 (2006) | “CYTOKINE” MODEL OF PATHOGENESIS OF CHRONIC HEART FAILURE AND THE OPPORTUNITIES OF NEW THERAPEUTIC STRATEGY IN DECOMPENSATED PATIENTS | Abstract similar documents |
| U. A. Vasuk, O. P. Dudarenko, E. N. Uschuk, E. L. Schkolnik, M. K. Serova | ||
| "... Neurohumoral model of pathogenesis of chronic heart failure (emCHF/em) made it possible to develop new ..." | ||
| Vol 8, No 4 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpygina | ||
| "... a dose of a embeta/em-emblocker/em was doubled, then amlodipine was added in the dose of 5 mg daily with its ..." | ||
| Vol 9, No 1 (2013) | OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS | Abstract PDF (Eng) similar documents |
| S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap | ||
| "... with arterial hypertension (HT), ischemic heart disease (IHD), chronic heart failure (emCHF/em) and atrial ..." | ||
| Vol 14, No 5 (2018) | Chronic Heart Failure in Rheumatoid Arthritis Patients (Part I): Prevalence, Etiology and Pathogenesis | Abstract similar documents |
| D. S. Novikova, I. G. Kirillova, H. V. Udachkina, T. V. Popkova | ||
| "... , in particular, by an increased incidence of chronic heart failure (emCHF/em). Analysis of the results of the main ..." | ||
| Vol 18, No 1 (2022) | Polymorbidity and Polypragmasia in High and Very High Cardiovascular Risk Patients | Abstract similar documents |
| N. V. Izmozherova, A. A. Popov, A. A. Kuryndina, E. I. Gavrilova, M. A. Shambatov, V. M. Bakhtin | ||
| "... . Thus, 87.5% emCHF/em patients were receiving renin-angiotensin-aldosterone system emblockers/em. Statins were ..." | ||
| Vol 15, No 6 (2019) | Chronic Heart Failure in Rheumatoid Arthritis Patients (Part III): Effects of Antirheumatic Drugs | Abstract similar documents |
| D. S. Novikova, H. V. Udachkina, I. G. Kirillova, T. V. Popkova | ||
| "... heart failure (emCHF/em) in rheumatoid arthritis (RA). The purpose of the review is to analyze the results ..." | ||
| Vol 4, No 2 (2008) | INHIBITOR OF SYNTHESIS OF TUMOR NECROSIS FACTOR-Α, PENTOXIFYLLINE, IN COMBINED THERAPY OF THE CHRONIC HEART FAILURE | Abstract similar documents |
| O. P. Dudarenko, E. L. Shkol’nik, , , | ||
| "... failure (emCHF/em) complicated ischemic heart disease (IHD). Material and methods. 55 patients with emCHF/em ..." | ||
| Vol 18, No 5 (2022) | Insulin-like Growth Factor-1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Origin | Abstract similar documents |
| A. N. Zakirova, N. E. Zakirova, D. F. Nizamova | ||
| "... remodeling and fibrosis in patients with chronic heart failure (emCHF/em) of ischemic origin. Material and methods ..." | ||
| Vol 17, No 2 (2021) | Management of Patients with Chronic Heart Failure and Diabetes Mellitus | Abstract similar documents |
| E. V. Reznik, T. L. Nguyen, G. N. Golukhov | ||
| "... Chronic heart failure (emCHF/em) occurs in 4.3-28% of patients with diabetes mellitus and is most often ..." | ||
| Vol 8, No 5 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpigina | ||
| "... daily. If the effect was insufficient a dose of a embeta/em-emblocker/em was doubled, then amlodipine was added ..." | ||
| Vol 17, No 1 (2021) | Transforming Growth Factor β1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Genesis | Abstract similar documents |
| N. E. Zakirova, A. N. Zakirova, D. F. Nizamova | ||
| "... remodeling and fibrosis in patients with chronic heart failure (emCHF/em) of ischemic origin. Material ..." | ||
| Vol 5, No 3 (2009) | RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov | ||
| "... erectile dysfunction. Age, blood pressure level, abdominal obesity, embeta/em-emblocker/em therapy and chronic heart ..." | ||
| Vol 9, No 1 (2013) | ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION | Abstract similar documents |
| A. N. Zakirova, E. R. Abdukova, N. E. Zakirova | ||
| "... fibrillation (AF) in patients with ischemic heart disease (IHD) complicated by chronic heart failure (emCHF/em ..." | ||
| Vol 6, No 5 (2010) | INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract PDF (Eng) similar documents |
| E. N. Golovenko, D. A. Napalkov, V. A. Sulimov | ||
| "... Background. Chronic heart failure (emCHF/em) progression is accompanied by remodeling of muscular ..." | ||
| Vol 11, No 2 (2015) | DIAGNOSTIC VALUE OF GALECTIN-3 LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES | Abstract similar documents |
| A. A. Snetkova, N. Yu. Timofeeva, V. S. Zadionchenko | ||
| "... failure (emCHF/em). Galectin-3, a marker of fibrosis and inflammation, has shown himself as a biomarker of emCHF/em ..." | ||
| Vol 6, No 3 (2010) | IS THERE AN ALTERNATIVE TO EJECTION FRACTION IN INSTRUMENTAL EVALUATION OF CHRONIC HEART FAILURE SEVERITY IN POST-MYOCARDIAL INFARCTION PATIENTS? | Abstract similar documents |
| T. A. Kazakovtseva, N. A. Shostak | ||
| "... evaluation of chronic heart failure (emCHF/em) severity in post-myocardial infarction patients. Material ..." | ||
| Vol 16, No 1 (2020) | Chronic Heart Failure in Early Rheumatoid Arthritis Patients Prior to Basic Antirheumatic Therapy | Abstract PDF (Eng) similar documents |
| I. G. Kirillova, D. S. Novikova, T. V. Popkova, H. V. Udachkina, E. I. Markelova, Yu. N. Gorbunova, Yu. O. Korsakova, S. N. Gluchova | ||
| "... heart failure (emCHF/em) in patients with early rheumatoid arthritis (RA) prior to anti-inflammatory therapy ..." | ||
| Vol 18, No 5 (2022) | Hepcidin as a Regulator of Iron Metabolism and Mediator of Inflammation in Patients with Chronic Heart Failure and Anemia of Chronic Diseases of the Elderly and Senile Age | Abstract similar documents |
| N. I. Solomakhina, A. S. Lishuta, A. V. Dementieva | ||
| "... of inflammation in elderly and senile patients with chronic heart failure (emCHF/em) with anemia of chronic diseases ..." | ||
| 1 - 100 of 378 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
